Plasma Intestinal Fatty Acid–Binding Protein Levels Correlate With Morphologic Epithelial Intestinal Damage in a Human Translational Ischemia-reperfusion Model
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIM: Intestinal fatty acid-binding protein (I-FABP) is a useful marker in the detection of intestinal ischemia. However, more insight into the test characteristics of I-FABP release is needed. This study aimed to investigate the relationship between plasma I-FABP levels and the severity of ischemic mucosal injury, and define the clinical usefulness of systemic I-FABP following ischemia. METHODS: In a human experimental model, 6 cm of the jejunum, to be removed for surgical reasons, was selectively exposed to either 15, 30, or 60 minutes of ischemia (I) followed by 30 and 120 minutes of reperfusion (R). Blood and tissue was sampled at all time points. Arteriovenous (V-A) concentration differences of I-FABP were measured. Tissue sections were stained with hematoxylin/eosin, and villus height was measured to score epithelial damage. RESULTS: Histologic analysis showed only minor reversible intestinal damage following 15 I and 30 I; however, severe irreversible epithelial damage was observed in the jejunum exposed to 60 I. I-FABP V-A differences paralleled the degree of tissue damage over time [7.79 (± 1.8) ng/mL, 128.6 (± 44.2) ng/mL, 463.3 (± 139.8) ng/mL for 15 I, 30 I and 60 I, respectively]. A good correlation was found between histologic epithelial damage and V-A I-FABP (r=-0.82, P<0.001). Interestingly, systemic I-FABP levels were significantly increased after 60 I of this short small intestinal segment. CONCLUSIONS: This study demonstrates the relationship between the duration of ischemia and the extent of tissue damage, which is reflected by I-FABP V-A plasma levels. In addition, systemic I-FABP levels appear valuable in detecting irreversible intestinal ischemia-reperfusion damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Menke, J. (2010) · Radiology · doi:10.1148/radiol.10091938 · Cited by 319
Current status on plasma biomarkers for acute mesenteric ischemia
Acosta, S., & Nilsson, T. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0660-z · Cited by 157
Cited by
Metabolic functions of FABPs—mechanisms and therapeutic implications
Hotamisligil, G. S., & Bernlohr, D. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.122 · Cited by 712
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
Schoultz, I., & Keita, Å. V. (2020) · Cells · doi:10.3390/cells9081909 · Cited by 467
Stoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30182-5 · Cited by 435
Biochemical markers of acute intestinal ischemia: Possibilities and limitations
Montagnana, M., Danese, E., & Lippi, G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.07.22 · Cited by 108
Serological markers for human intestinal ischemia: A systematic review
Derikx, J. P. M., Schellekens, D. H. S. M., & Acosta, S. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.01.004 · Cited by 96
Self-citationDiagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far
Peoc’h, K., Nuzzo, A., Guedj, K., Paugam, C., & Corcos, O. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0291 · Cited by 86
“[54] evidenced a correlation between the duration of ischemia and the increase of serum I-FABP.”
BackgroundAcute Mesenteric Ischemia Among Postcardiac Surgery Patients Presenting with Multiple Organ Failure
Guillaume, A., Pili-Floury, S., Chocron, S., Delabrousse, E., De Parseval, B., Koch, S., Samain, E., Capellier, G., & Piton, G. (2017) · Shock · doi:10.1097/shk.0000000000000720 · Cited by 68
Bourcier, S., Klug, J., & Nguyen, L. S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.4088 · Cited by 65
Wang, X., Liu, G., Gao, Q., Li, N., & Wang, R. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13196 · Cited by 51
Bourcier, S., Ulmann, G., Jamme, M., Savary, G., Paul, M., Benghanem, S., Lavillegrand, J.-R., Schmidt, M., Luyt, C.-E., Maury, E., et al. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01092-8 · Cited by 37
“In particular, experimental studies demonstrated early increase of I-FABP after gut ischemia onset [28, 29].”
BackgroundRittgerodt, N., Pape, T., Busch, M., Becker, L. S., Schneider, A., Wedemeyer, H., Seeliger, B., Schmidt, J., Hunkemöller, A. M., Fuge, J., et al. (2022) · Critical Care · doi:10.1186/s13054-022-03962-w · Cited by 26
Ludewig, S., Jarbouh, R., Ardelt, M., Mothes, H., Rauchfuß, F., Fahrner, R., Zanow, J., & Settmacher, U. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/2795176 · Cited by 25
“I-FABP is abundant only at the tips of the villi of bowel mucosa and rapidly released into the circulation in case of severe mucosal ischemia [13, 14, 17, 18].”
BackgroundTräger, J., Melichar, V. O., Meyer, R., Rauh, M., Bogdan, C., & Held, J. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0614-8 · Cited by 7
Metadata
- Authors
- Schellekens, D. H. S. M., Grootjans, J., Dello, S. A. W. G., van Bijnen, A. A., van Dam, R. M., Dejong, C. H. C., Derikx, J. P. M., & Buurman, W. A.
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2014-03
- Volume
- 48
- Issue
- 3
- Pages
- 253-260
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2071713127
- Cited by
- 141
- References
- 2
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.